3-hydroxyflavone has been researched along with Cell Transformation, Viral in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, H; Ito, C; Itoigawa, M; Miyamoto, Y; Mukainaka, T; Nishino, H; Okuda, Y; Rao, KS; Takayasu, J; Tokuda, H | 1 |
| Carrasco, L; Guinea, R; López-Rivas, A | 1 |
| Bonneau, AM; Sonenberg, N | 1 |
3 other study(ies) available for 3-hydroxyflavone and Cell Transformation, Viral
| Article | Year |
|---|---|
A new biflavonoid from Calophyllum panciflorum with antitumor-promoting activity.
Topics: Antineoplastic Agents; Cell Line; Cell Transformation, Viral; Flavonoids; Flavonols; Herpesvirus 4, Human; Humans; Magnetic Resonance Spectroscopy; Models, Chemical; Trees | 1999 |
Modification of phospholipase C and phospholipase A2 activities during poliovirus infection.
Topics: Antiviral Agents; Arachidonic Acid; Arachidonic Acids; Calcimycin; Cell Transformation, Viral; Cycloheximide; Flavonols; HeLa Cells; Humans; Hygromycin B; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Kinetics; Phospholipases; Phospholipases A; Phospholipases A2; Poliovirus; Quercetin; Type C Phospholipases | 1989 |
Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection.
Topics: Antiviral Agents; Carrier Proteins; Cell Transformation, Viral; Flavonols; Guanidine; Guanidines; HeLa Cells; Humans; Poliovirus; Protein Biosynthesis; Quercetin; RNA Cap-Binding Proteins; RNA Caps; RNA, Messenger; Transcription, Genetic | 1987 |